{
      "StudyFieldsResponse": {
            "APIVrs": "1.01.05",
            "DataVrs": "2022:10:06 23:25:58.836",
            "Expression": "mesenchymal placental",
            "NStudiesAvail": 430108,
            "NStudiesFound": 26,
            "MinRank": 1,
            "MaxRank": 1000,
            "NStudiesReturned": 26,
            "FieldList": [
                  "MaximumAge",
                  "MinimumAge",
                  "NCTId",
                  "NCTIdAlias",
                  "OfficialTitle",
                  "OrgClass",
                  "OrgFullName",
                  "OrgStudyId",
                  "OrgStudyIdDomain",
                  "OrgStudyIdLink",
                  "OrgStudyIdType",
                  "OtherEventAssessmentType",
                  "OtherEventNotes",
                  "OtherEventOrganSystem",
                  "OtherEventSourceVocabulary"
            ],
            "StudyFields": [
                  {
                        "Rank": 1,
                        "MaximumAge": [
                              "75 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT04464213"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Phase I Clinical Trials of Human Placental Mesenchymal Stem Cells Treatment on Diabetic Foot Ulcer"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Beijing Tongren Hospital"
                        ],
                        "OrgStudyId": [
                              "HS201901"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 2,
                        "MaximumAge": [
                              "80 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT01413035"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Safety/Efficacy Assessed Study on Transplantation Therapy Using Human Umbilical Cord/Placenta-derived Mesenchymal Stem Cells for Type 2 Diabetes Mellitus"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Shandong University"
                        ],
                        "OrgStudyId": [
                              "diabetes"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 3,
                        "MaximumAge": [
                              "70 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT05499156"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Safety of Injection of Placental Mesenchymal Stem Cell Derived Exosomes for Treatment of Resistant Perianal Fistula in Crohn's Patients"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Tehran University of Medical Sciences"
                        ],
                        "OrgStudyId": [
                              "IRCT20200413047063N3"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 4,
                        "MaximumAge": [
                              "80 Years"
                        ],
                        "MinimumAge": [
                              "40 Years"
                        ],
                        "NCTId": [
                              "NCT01385644"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "A Phase I Study to Evaluate the Potential Role of Mesenchymal Stem Cells in the Treatment of Idiopathic Pulmonary Fibrosis"
                        ],
                        "OrgClass": [
                              "OTHER_GOV"
                        ],
                        "OrgFullName": [
                              "The Prince Charles Hospital"
                        ],
                        "OrgStudyId": [
                              "HREC/09/QPCH/105"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [
                              "All pateints experienced halitosis post infusion"
                        ],
                        "OtherEventOrganSystem": [
                              "Respiratory, thoracic and mediastinal disorders"
                        ],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 5,
                        "MaximumAge": [
                              "70 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT05402748"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Safety and Efficacy of Injection of Human Placenta Mesenchymal Stem Cells Derived Exosomes for Treatment of Complex Anal Fistula"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Tehran University of Medical Sciences"
                        ],
                        "OrgStudyId": [
                              "IRCT20211212053361N1"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 6,
                        "MaximumAge": [],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT02395029"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Evaluate the Safety and Feasibility of Injecting Placental Matrix-Derived Mesenchymal Stem Cells Into the Penis to Treat the Symptoms of Peyronie's Disease"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Z Urology"
                        ],
                        "OrgStudyId": [
                              "PMD-MSC-PD-01"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 7,
                        "MaximumAge": [
                              "70 Years"
                        ],
                        "MinimumAge": [
                              "40 Years"
                        ],
                        "NCTId": [
                              "NCT02398370"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Evaluate the Safety and Feasibility of Injecting Placental Matrix-Derived Mesenchymal Stem Cells Into the Penis to Treat the Symptoms of Mild to Moderate Erectile Dysfunction"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Z Urology"
                        ],
                        "OrgStudyId": [
                              "PMD-MSC-ED-01"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 8,
                        "MaximumAge": [
                              "75 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT04453111"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Efficacy of Bone-marrow-derived and Placenta-derived Multipotent Mesenchymal Stem / Stromal Cells for Osteoarthritis"
                        ],
                        "OrgClass": [
                              "INDUSTRY"
                        ],
                        "OrgFullName": [
                              "Institute of Cell Therapy"
                        ],
                        "OrgStudyId": [
                              "#7/09.26.2018"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 9,
                        "MaximumAge": [
                              "25 Weeks"
                        ],
                        "MinimumAge": [
                              "19 Weeks"
                        ],
                        "NCTId": [
                              "NCT04652908"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Phase 1/2a Trial of Placental Mesenchymal Stem Cells for Repair of Fetal Myelomeningocele"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "University of California, Davis"
                        ],
                        "OrgStudyId": [
                              "1617774"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 10,
                        "MaximumAge": [
                              "60 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT01420432"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Phase II Study of Umbilical Cord/Placenta-Derived Mesenchymal Stem Cells to Treat AS"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Shandong University"
                        ],
                        "OrgStudyId": [
                              "Zhangni"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 11,
                        "MaximumAge": [
                              "80 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT01182662"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Phase II Study of Umbilical Cord/Placenta-Derived Mesenchymal Stem Cells to Treat SAA"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Shandong University"
                        ],
                        "OrgStudyId": [
                              "kongdx"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 12,
                        "MaximumAge": [
                              "80 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT01129739"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Phase II Study of Umbilical Cord/Placenta-Derived Mesenchymal Stem Cells to Treat RA and RARS of MDS"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Shandong University"
                        ],
                        "OrgStudyId": [
                              "CZheng"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 13,
                        "MaximumAge": [
                              "75 Years"
                        ],
                        "MinimumAge": [
                              "40 Years"
                        ],
                        "NCTId": [
                              "NCT03028428"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Clinical Research on Intra-articular Injection of Human Autologous MSCs in Treatment of Knee OA"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Affiliated Hospital of Jiangsu University"
                        ],
                        "OrgStudyId": [
                              "AHJiangsuU-FSK-MSC-OA"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 14,
                        "MaximumAge": [
                              "75 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT05387278"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Safety and Effectiveness of Placental Derived Exosomes and Umbilical Cord Mesenchymal Stem Cells in Moderate to Severe Acute Respiratory Distress Syndrome (ARDS) Associated With the Novel Corona Virus Infection (COVID-19)"
                        ],
                        "OrgClass": [
                              "INDUSTRY"
                        ],
                        "OrgFullName": [
                              "Vitti Labs, LLC"
                        ],
                        "OrgStudyId": [
                              "EW-01"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 15,
                        "MaximumAge": [
                              "75 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT04461925"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Treatment of Coronavirus COVID-19 Pneumonia (Pathogen SARS-CoV-2) With Cryopreserved Allogeneic Multipotent Mesenchymal Stem Cells of the Placenta and Umbilical Cord"
                        ],
                        "OrgClass": [
                              "INDUSTRY"
                        ],
                        "OrgFullName": [
                              "Institute of Cell Therapy"
                        ],
                        "OrgStudyId": [
                              "#4/24.04.2020"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 16,
                        "MaximumAge": [
                              "40 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT03489564"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "The Effect of Physical Activity on in Vivo and in Vitro Mitochondrial Capacity in Pregnant Women"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Pennington Biomedical Research Center"
                        ],
                        "OrgStudyId": [
                              "PBRC 2017-065"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 17,
                        "MaximumAge": [
                              "85 Years"
                        ],
                        "MinimumAge": [
                              "50 Years"
                        ],
                        "NCTId": [
                              "NCT03337243"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Effect of Implanting Allogenic Cytokines Derived From Human Amniotic Membrane (HAM) and Mesenchymal Stem Cells Derived From Human Umbilical Cord Wharton's Jelly (HUMCWJ) on Pain and Functioning of Knee Osteoarthritis"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Sport and Spine Rehab Clinical Research Foundation"
                        ],
                        "OrgStudyId": [
                              "StemCell"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 18,
                        "MaximumAge": [
                              "81 Years"
                        ],
                        "MinimumAge": [
                              "40 Years"
                        ],
                        "NCTId": [
                              "NCT00919958"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Phase I Study of Intramuscular (IM) Injection of Allogeneic PLX-PAD Cells for the Treatment of Critical Limb Ischemia. PLX-PAD Are Mesenchymal-like Stromal Cells Derived From a Full Term Placenta. These Placental Adherent Stromal Cells (ASCs) Are Expanded in the Company's Proprietary PluriXTM 3D Bioreactor System. PLX Cells Are Immune Privileged and Possess Immunomodulatory Properties."
                        ],
                        "OrgClass": [
                              "INDUSTRY"
                        ],
                        "OrgFullName": [
                              "Pluristem Ltd."
                        ],
                        "OrgStudyId": [
                              "PLX-PAD 1202-1"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 19,
                        "MaximumAge": [],
                        "MinimumAge": [],
                        "NCTId": [
                              "NCT00749164"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Allogeneic Mesenchymal Stem Cell Infusion for Treatment Of Steroid Resistant GVHD"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Hadassah Medical Organization"
                        ],
                        "OrgStudyId": [
                              "IBR-0137-08-HMO-CTIL"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 20,
                        "MaximumAge": [
                              "81 Years"
                        ],
                        "MinimumAge": [
                              "40 Years"
                        ],
                        "NCTId": [
                              "NCT00951210"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Phase I Study of Intramuscular (IM) Injections of Allogeneic PLX-PAD Cells for the Treatment of Critical Limb Ischemia. PLX-PAD Are Mesenchymal-Like Stromal Cells Derived From a Full Term Placenta."
                        ],
                        "OrgClass": [
                              "INDUSTRY"
                        ],
                        "OrgFullName": [
                              "Pluristem Ltd."
                        ],
                        "OrgStudyId": [
                              "1202-2"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 21,
                        "MaximumAge": [
                              "85 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT04614025"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "A Randomized, Controlled, Multicenter, Parallel-Group Phase IIa Study to Evaluate the Efficacy and Safety of Intramuscular Injections of PLX-PAD for the Treatment of Severe COVID-19"
                        ],
                        "OrgClass": [
                              "INDUSTRY"
                        ],
                        "OrgFullName": [
                              "Pluristem Ltd."
                        ],
                        "OrgStudyId": [
                              "PLX-COV-03"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 22,
                        "MaximumAge": [
                              "75 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT01795950"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "A Phase I Safety and Pharmacodynamic Study of Intravenous Infusion of PLX-PAD Cells in Patients With PAH"
                        ],
                        "OrgClass": [
                              "INDUSTRY"
                        ],
                        "OrgFullName": [
                              "United Therapeutics"
                        ],
                        "OrgStudyId": [
                              "PLX-PH-101"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 23,
                        "MaximumAge": [
                              "80 Years"
                        ],
                        "MinimumAge": [
                              "40 Years"
                        ],
                        "NCTId": [
                              "NCT04389450"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Parallel-Group Phase II Study to Evaluate the Efficacy and Safety of Intramuscular Injections of PLX PAD for the Treatment of Severe COVID-19"
                        ],
                        "OrgClass": [
                              "INDUSTRY"
                        ],
                        "OrgFullName": [
                              "Pluristem Ltd."
                        ],
                        "OrgStudyId": [
                              "PLX-COV-01"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 24,
                        "MaximumAge": [
                              "48 Hours"
                        ],
                        "MinimumAge": [
                              "0 Hours"
                        ],
                        "NCTId": [
                              "NCT03635450"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "A Phase I Study of hCT-MSC, an Umbilical Cord-Derived Mesenchymal Stromal Cell Product, in Newborn Infants With Moderate or Severe Hypoxic- Ischemic Neonatal Encephalopathy."
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Duke University"
                        ],
                        "OrgStudyId": [
                              "Pro00100253"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 25,
                        "MaximumAge": [
                              "40 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT02926079"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Investigation of Mechanisms for Transmission of Impaired Glucose Metabolism in Infants Exposed to Diabetes in Utero"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Pennington Biomedical Research Center"
                        ],
                        "OrgStudyId": [
                              "PBRC 2016-071"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 26,
                        "MaximumAge": [
                              "40 Years"
                        ],
                        "MinimumAge": [
                              "20 Years"
                        ],
                        "NCTId": [
                              "NCT01649752"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Phase I Study of Role of Stem Cells in Improving Implantation Rates in ICSI Patients"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Kasr El Aini Hospital"
                        ],
                        "OrgStudyId": [
                              "Stem cells and implantation"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  }
            ]
      }
}